Market Entry - Hospital Acquired Disease Testing Market in Israel: Analysis of Growth, Trends and Progress (2020 - 2025)

Looking to buy the report?

About the Market

In the past few years, the high incidence of nosocomial infections or hospital acquired infections (HAIs) has led to a high rate of morbidity and has emerged as a major concern for governments, particularly in developing and underdeveloped countries. In first world countries, various regulations are in place for penalizing hospitals exhibiting high incidences of HAIs, auguring well for the hospital acquired disease testing market. In contrast, the absence of proper regulations and stringent policies limiting the adoption of molecular-biology-based diagnostics are restricting the expansion of the market across emerging nations. By tests, this market is segmented into urinary tract, pneumonia, bloodstream-associated, MRSA, surgical site infections etc. The hospital acquired urinary tract infection diagnostics segment holds a dominating share in the overall market, due to its high prevalence and impact on morbidity. Additionally, the market for testing solutions such as surgical site infections and pneumonia (ventilator-associated and hospital-associated infections) shall also expand due to the growing incidence of these conditions in emerging economies of Latin America, Asia-Pacific, and other developing regions. Some of the key players in global hospital acquired disease testing market are Diatherix Laboratories Inc., Qiagen GmbH, Gen-Probe Inc., L Hoffman-La Roche, Cepheid Inc., Meridian Biosciences, Life Technologies Corporation, Nordion Inc., and Cantel Medical Corporation.

About the Geography

Israel is a small country located in the Middle East bordered by Egypt, Jordan, Lebanon, and Syria. Israel has a liberal investment system and most activities are open to both private nationals and foreign investors. It has many tech start-ups, funded by America, a strong R7D sector, and a highly skilled multi-lingual workforce.

The government encourages entrepreneurship and the country is the second largest regarding the availability of venture capital. The recent revision of Encouragement of Capital Investments Law now includes financial incentives for foreign investments. Israel is bordered by countries with on-going wars and terrorist activities, which act as a major impediment for foreign investors. It also has high corporate taxes and cost of manpower.

Israel invests almost 5% of its GDP in R&D and has many highly qualified engineers with access to funds. For these reasons, Israel is a good country to invest in if a company wants to set up an R&D wing, branch office, or LLC.

 

Component Name

Unit

GDP (USD billion)

296

GDP Annual Growth Rate

3.2

GDP Per Capita

32828

Unemployment Rate

4.6

Wages

2563.21

Inflation Rate

-0.7

Consumer Price Index (CPI)

99.2

Interest Rate

0.1

Loans to Private Sector (USD billion)

150.026

Balance of Trade (USD billion)

-1.899

Business Confidence

19.2

Manufacturing PMI (Index Points)

57 Index Points

Ease of Doing Business

53

Competitiveness Rank

24

Corruption Rank

32

Consumer Confidence

-14.51

Consumer Spending (USD billion)

41.537

Bank Lending Rate (Consumers)

3.4

Corporate Tax Rate

26.5

Sales Tax Rate

18

            

The Market Entry Series

Exploring global markets is now recognized as the shortest way to ensure high time to efficiency conversion, when trying to expand revenues past domestic markets, for firms both large and small. Our market entry series, priced suitably low contains the essentials of all the parameters (Refer: Table of Contents) you must be apprised of before you can have a well informed contemplation of a business opportunity in your choice of industry, in your choice of geography.

1. Introduction

                1.1 Scope of the Report

                1.2 Regional Analysis

                                1.2.1 PESTLE Analysis

                                1.2.2 Analysis of Ease of Doing Business

2. Market Dynamics

                2.1 Drivers

                2.2 Restraints

                2.3 Opportunities

3. Market Demand Analysis

                3.1 Socio-Economic Segmentation

                3.2 Demographic Strengths & Weaknesses

                3.3 Spending Patterns

                3.4 Target Market Identification

4. Market Size of Hospital Acquired Disease Testing Market (USD millions)

                4.1 By Tests

                4.2 By Methods

                4.3 By End Users

5. Market Entry

                5.1 Market Entry: The Strategy

                                5.1.1 Types of Entry Modes, by Market Entry Objectives

                                5.1.2 Competition Analysis

                                                5.1.2.1 Market Share

                                                5.1.2.2 Strategies Adopted, Recent Events 

                                5.1.3 Pricing Strategy

                                5.1.4 Supply Chain Analysis

                                                5.1.4.1 Trade (Import-Export Analysis)

                                                5.1.4.2 Distribution Network & Retail Analysis

                5.2 Market Entry: The Administration

                                5.2.1 How to Register a Company (Flowchart)

                                5.2.2 Registration Processes 

                                                5.2.2.1 Ministries Involved

                                                5.2.2.2 Criteria and Conditions

                                5.2.3 List of Forms & Documents

                                5.2.4 Product Control Guidelines specified by the Government

6. Sources

7. Disclaimer

Looking to buy the report?

Need a report that reflects how COVID-19 has impacted this market and its growth?

Looking to customize report?

Email

Message

By submitting, you confirm that you agree to our privacy policy